矩子科技(300802.SZ):機器視覺設備主要包括應用於PCBA工藝環節和MiniLED生產環節的2D/3D自動光學檢測設備
格隆匯11月26日丨矩子科技(300802.SZ)在投資者關係表示,公司機器視覺設備主要包括應用於PCBA工藝環節和MiniLED生產環節的2D/3D自動光學檢測設備(AOI)、錫膏檢測設備(SPI);應用於半導體封測PostDicing工藝環節以及鍵合工藝環節的AOI;應用於PCBA以及半導體功率器件內部缺陷檢測的3D-CT在線X-ray檢測設備(AXI);以及高速高精度點膠機、鐳雕機等產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.